What CHINOOK THERAPEUTICS, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Akkaraju Srinivas | Director | Aug 11 | Disposition to Issuer · D | −5,161,888 | — | — | 0 |
| Akkaraju Srinivas | Director | Aug 11 | Disposition to Issuer · D | −3,300 | — | — | 0 |
| Bjerkholt Eric | Chief Financial Officer | Aug 11 | Disposition to Issuer · D | −39,371 | — | — | 0 |
| Greenman William Mariner | Director | Aug 11 | Disposition to Issuer · D | −23,643 | — | — | 0 |
| Dobmeier Eric | President, CEO | Aug 11 | Disposition to Issuer · D | −301,138 | — | — | 0 |
| Burris Michelle | Director | Aug 11 | Disposition to Issuer · D | −3,300 | — | — | 0 |
| Krishnan Mahesh | Director | Aug 11 | Disposition to Issuer · D | −1,275 | — | — | 0 |
| Jerel Davis | Director | Aug 11 | Disposition to Issuer · D | −210,996 | — | — | 0 |
| Jerel Davis | Director | Aug 11 | Disposition to Issuer · D | −719,104 | — | — | 0 |
| Jerel Davis | Director | Aug 11 | Disposition to Issuer · D | −2,105,107 | — | — | 0 |
| Jerel Davis | Director | Aug 11 | Disposition to Issuer · D | −447,013 | — | — | 0 |
| Frohlich Tom | Chief Operating Officer | Aug 11 | Disposition to Issuer · D | −150,777 | — | — | 0 |
| King Andrew James | Chief Scientific Officer | Aug 11 | Disposition to Issuer · D | −19,157 | — | — | 0 |
| Thomas Dolca | Director | Aug 11 | Disposition to Issuer · D | −13,300 | — | — | 0 |
| King Andrew James | Chief Scientific Officer | Aug 01 | Open-market sale · S | −1,168 | $39.03 | −$45.6K | 19,157 |
| King Andrew James | Chief Scientific Officer | Jul 29 | Exercise / conversion · M | +3,333 | — | — | 20,325 |
| Greenman William Mariner | Director | May 30 | Open-market sale · S | −1,155 | $23.30 | −$26.9K | 23,643 |
| Akkaraju Srinivas | Director | May 26 | Exercise / conversion · M | +3,300 | — | — | 3,300 |
| Greenman William Mariner | Director | May 26 | Exercise / conversion · M | +3,300 | — | — | 24,798 |
| Burris Michelle | Director | May 26 | Exercise / conversion · M | +3,300 | — | — | 3,300 |
Loading...